Morgan Stanley Cuts Ryan Specialty (NYSE:RYAN) Price Target to $50.00

Ryan Specialty (NYSE:RYAN) had its price objective lowered by Morgan Stanley from $55.00 to $50.00 in a research report sent to investors on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

RYAN has been the topic of a number of other research reports. Cantor Fitzgerald decreased their target price on Ryan Specialty from $52.00 to $45.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 17th. Piper Sandler cut their price target on shares of Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating for the company in a report on Friday, February 13th. Royal Bank Of Canada started coverage on shares of Ryan Specialty in a research report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 price objective for the company. Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating on the stock in a report on Friday, February 13th. Finally, Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $65.00 to $55.00 and set an “outperform” rating for the company in a research note on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and a consensus price target of $52.44.

Ryan Specialty Price Performance

Shares of Ryan Specialty stock opened at $34.90 on Monday. The firm has a market cap of $9.22 billion, a PE ratio of 83.10, a P/E/G ratio of 0.88 and a beta of 0.71. Ryan Specialty has a twelve month low of $31.50 and a twelve month high of $75.26. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. The business has a 50-day moving average price of $38.73 and a 200 day moving average price of $48.64.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The business had revenue of $751.21 million for the quarter, compared to analysts’ expectations of $777.43 million. Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The business’s revenue for the quarter was up 13.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.45 EPS. Sell-side analysts predict that Ryan Specialty will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th were paid a $0.13 dividend. The ex-dividend date of this dividend was Tuesday, February 24th. This represents a $0.52 annualized dividend and a yield of 1.5%. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.12. Ryan Specialty’s dividend payout ratio is currently 123.81%.

Insiders Place Their Bets

In other Ryan Specialty news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the stock in a transaction on Monday, February 23rd. The shares were bought at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the purchase, the director directly owned 428,295 shares in the company, valued at $17,114,668.20. This trade represents a 6.33% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 52.21% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

Hedge funds and other institutional investors have recently modified their holdings of the business. Advisory Services Network LLC purchased a new stake in Ryan Specialty during the 3rd quarter valued at about $28,000. Los Angeles Capital Management LLC purchased a new position in Ryan Specialty in the 4th quarter worth approximately $25,000. SBI Securities Co. Ltd. lifted its stake in Ryan Specialty by 6,322.2% in the 4th quarter. SBI Securities Co. Ltd. now owns 578 shares of the company’s stock worth $30,000 after purchasing an additional 569 shares in the last quarter. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Ryan Specialty by 83.7% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 599 shares of the company’s stock worth $35,000 after purchasing an additional 273 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in shares of Ryan Specialty by 65.4% during the 3rd quarter. Fifth Third Bancorp now owns 612 shares of the company’s stock worth $34,000 after purchasing an additional 242 shares during the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty News Summary

Here are the key news stories impacting Ryan Specialty this week:

• Positive Sentiment: UBS trimmed its price target to $59 from $65 but kept a “buy” rating and still projects large upside versus current levels. Article Title Tickerreport
• Positive Sentiment: Goldman Sachs lowered its target to $49 from $57 but maintained a “buy” view, signaling confidence in medium-term growth despite nearer-term pressure. Article Title
• Positive Sentiment: Keefe, Bruyette & Woods cut its target to $49 from $55 and kept an “outperform” rating, continuing the pattern of lowered targets but sustained positive ratings. Article Title Tickerreport
• Positive Sentiment: Barclays trimmed its target to $41 (from $45) while keeping an “overweight” rating, indicating a more modest but still-positive upside case. Article Title
• Positive Sentiment: Morgan Stanley lowered its price target to $50 in a separate note, another example of analysts dialing back targets without turning negative on the name. Morgan Stanley note
• Neutral Sentiment: Broader analyst coverage roundup — The Globe and Mail ran a piece compiling analyst comments on financials including Ryan Specialty; useful for context but not a single actionable change. Globe and Mail

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.